Clonidine transdermal system (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Clonidine transdermal system drug offered from Actavis Pharma, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Clonidine |
| SUBSTANCE NAME: | CLONIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-05-06 |
| END MARKETING DATE: | 0000-00-00 |
Clonidine transdermal system HUMAN PRESCRIPTION DRUG Details:
| Item Description | Clonidine transdermal system from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.1(mg/d) |
| START MARKETING DATE: | 2014-05-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3508_7c40121c-8149-4608-8874-8bd5878a7132 |
| PRODUCT NDC: | 0591-3508 |
| APPLICATION NUMBER: | ANDA090873 |
Other CLONIDINE Pharmaceutical Manufacturers / Labelers:
